Screener
AbCellera Biologics Inc. ABCL Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: AbCellera Biologics Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:28 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001703057-26-000046
FAQ
- What is AbCellera Biologics Inc.'s total assets?
- AbCellera Biologics Inc. (ABCL) reported total assets of $1.31B in Q2 2026.
- How has AbCellera Biologics Inc.'s total assets changed year-over-year?
- AbCellera Biologics Inc.'s total assets decreased by 6.7% year-over-year, from $1.4B to $1.31B.
- What is the long-term trend for AbCellera Biologics Inc.'s total assets?
- Over 5 years (2020 to 2025), AbCellera Biologics Inc.'s total assets has grown at a 6.2% compound annual growth rate (CAGR), from $1.01B to $1.36B.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.
Ask your AI about AbCellera Biologics Inc.'s total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude